Becker's Muscular Dystrophy clinical trials
9 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
- Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
- Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Duchenne Electronic Health Record Study
- Biomarker Development for Muscular Dystrophies
- The Duchenne Registry
- Molecular Analysis of Patients With Neuromuscular Disease
- Urinary Titin Biomarker in DMD
- Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Becker's Muscular Dystrophy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.